Clinical Trials Update: June 1, 2005
Spinal Cord Disorders Nerve Injury Recurrent Respiratory Papillomatosis
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Spinal Cord Disorders
The BrainGate Neural Interface System is designed to allow quadriplegics who are unable to use their hands due to spinal cord injury, stroke or muscular dystrophy to communicate with a computer using thoughts. You must be unable to use hands due to spinal cord injury, stroke or muscular dystrophy, be in general good health, live within a 2-hour drive of study site, speak English understandably, give informed consent and have committed family member/caregiver. Research sites located in Massachusetts, Illinois and Rhode Island.
If you are 18 years or older, you may qualify to participate in our Phase II research study that will evaluate the safety and effectiveness of an investigational pain medication. Study visits, exams, laboratory work, and investigational medication are provided at no cost. Research site located in Owings Mills, Md.
Recurrent Respiratory Papillomatosis
This study is to determine the safety and effectiveness of an experimental new drug for the treatment of recurrent respiratory papillomatosis. You may qualify for this study if you are between two and 18 years old and have had surgery for this condition at least three times in the past year. Research site located in New Hyde Park, NY.
Copyright 2005 CenterWatch. All rights reserved.